Anteris Technologies Ltd. (Anteris or the Company) Limited welcomed Dr. Karl Poon MB, BS, FRACP, CSANZ to Anteris' global Medical Advisory Board. Brisbane based Dr. Poon is an experienced interventional cardiologist with expertise in structural heart disease interventions and among Australia's most prolific implanters of TAVI devices. His Medical Advisory Board participation is a welcome addition as they continue building clinical validation for their novel DurAVRTM 3D single-piece transcatheter aortic heart valve.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.1 AUD | +2.81% | -1.95% | +4.96% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.96% | 252M | |
-6.23% | 181B | |
+2.59% | 114B | |
-2.75% | 68.29B | |
+5.32% | 52.24B | |
+7.61% | 44.3B | |
+5.30% | 42.73B | |
+25.17% | 32.52B | |
+17.57% | 26.02B | |
-2.66% | 25.91B |
- Stock Market
- Equities
- AVR Stock
- News Anteris Technologies Ltd
- Anteris Technologies Ltd Adds Karl Poon to its Global Medical Advisory Board